Efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia: Analysis of the ODYSSEY LONG TERM trial.
Sign Up to like & getrecommendations! Published in 2018 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2018.07.017
Abstract: BACKGROUND AND AIMS Alirocumab, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9, significantly reduces low-density lipoprotein cholesterol (LDL-C). We evaluated the efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus (T2DM)… read more here.
Keywords: efficacy safety; without mdl; alirocumab; efficacy ... See more keywords
National Collegiate Athletic Association Swimmers With Glenohumeral Multidirectional Laxity Have an Increased Glenohumeral Joint Range of Motion Profile.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of sport rehabilitation"
DOI: 10.1123/jsr.2021-0183
Abstract: CONTEXT Adaptations in glenohumeral joint laxity and range of motion (ROM) are prevalent in competitive swimmers. Increased glenohumeral laxity in swimmers has been found to exist in multiple directions. However, it is unclear if swimmers… read more here.
Keywords: glenohumeral joint; motion; without mdl; laxity ... See more keywords